Story Poster
Photo by Jack Mackenzie - SicEm365.com
Baylor Football

The Monday Revue: What To Make Of Impressive Defensive Performance, Robertson's Struggles

November 25, 2024
1,314

Welcome to the ‘Monday Revue,’ where we break down the most important happenings from Baylor’s most recent game; this time, it's a win over a bad Houston squad.

It was a tepid performance. The offense somewhat sputtered for the first time in over a month while the defense handled its business against one of the nation’s worst offenses.

To continue reading, you must be a SicEm365 Premium subscriber.
Try Premium for $1
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial
Discussion from...

The Monday Revue: What To Make Of Impressive Defensive Performance, Robertson's Struggles

378 Views | 2 Replies | Last: 2 hrs ago by Dia del DougO
BluesBear
User Profile
Private Message
Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
8:17a
I don't think Sawyer struggled - he completed over 65% of his passes. First INT, a simple pump fake and it's a long TD. Second pick could have been saved if the WR made a break on the ball recognizing how far off the defender was. Our play calling in the second half was way more conservative and we were losing the battle in the trenches.
Reply Quote
Dia del DougO
User Profile
Private Message
Ignore User Stop Ignoring
How long do you want to ignore this user?
24 hours One week Permanently Cancel
9:57a
Baylor played against a dang good defense, and our defense played against a not-so-good offense.

It is still really tough to tell how the defense has progressed, though it is encouraging.

Offense seems legit.

Saturday is going to be a good test.

Sic 'em!
"The only true currency in this bankrupt world is what you share with someone else when you're uncool."
Reply Quote
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.